α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra and the formation of aggregates (Lewy bodies) in neurons. alpha-Synuclein is the major protein in Lewy bodies and rare mutations in alpha-synuclein cause early-onset PD. Consequently, alpha-synuclein is implicated in the pathogenesis of PD. Here, we have investigated the degradation pathways of alpha-synuclein, using a stable inducible PC12 cell model, where the expression of exogenous human wild-type, A30P, or A53T alpha-synuclein can be switched on and off. We have used a panel of inhibitors/stimulators of autophagy and proteasome function and followed alpha-synuclein degradation in these cells. We found that not only is alpha-synuclein degraded by the proteasome, but it is also degraded by autophagy. A role for autophagy was further supported by the presence of alpha-synuclein in organelles with the ultrastructural features of autophagic vesicles. Since rapamycin, a stimulator of autophagy, increased clearance of alpha-synuclein, it merits consideration as a potential therapeutic for Parkinsons disease, as it is designed for chronic use in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, mutant forms of synuclein and oligomers are dependent on the autophagy–lysosome pathway for their clearance4–6.”
From Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice (2018) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies suggest that α-synuclein is degraded by macroautophagy, chaperone-mediated autophagy, and the proteasome20–23.”
From Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration (2020) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Macroautophagy is a key pathway for the clearance of aggregate-prone cytosolic proteins.”
From Lithium induces autophagy by inhibiting inositol monophosphatase (2005) · cites this paper as Webb et al., 2003
In the citing paper
“Early evidence suggested roles for CMA and macroautophagy in degrading SNCA/α‐synuclein (Webb et al, 2003; Cuervo et al, 2004).”
From Autophagy in major human diseases (2021) · cites this paper as Webb et al, 2003
In the citing paper
“We previously showed that EGFP-HDQ74 is cleared by autophagy.”
From Lithium induces autophagy by inhibiting inositol monophosphatase (2005) · cites this paper as Webb et al., 2003
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Greene, L. A., & Tischler, A. S. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.7.2424 · Cited by 5,553
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
A Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,499
Research works printed but not linked: 2
- Furlong, R. A., Narain, Y., Rankin, J., Wyttenbach, A., and Rubinsztein, D. C. (2000) Biochem. J. 346, 577-581 · DOI · Paper page
- Biederbick, A., Kern, H. F., and Elsasser, H. P. (1995) Eur. J. Cell Biol. 66, 3-14
Cited by
Items 901–1,000 of 1,001
Chinese Medicine: A Hope for Neurodegenerative Diseases?
Law, B. Y. K., Wu, A., Wang, M. J., & Zhu, Y. Z. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170374 · Cited by 26
Gelais, C. S., Kim, S., Maksimova, V. V., Buzovetsky, O., Knecht, K. M., Shepard, C., Kim, B., Xiong, Y., & Wu, L. J. (2018) · Journal of Virology · doi:10.1128/jvi.01787-17 · Cited by 27
Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson’s Disease
Korkmaz, O. T., & Tunçel, N. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190111150953 · Cited by 27
Ganguly, U., Ganguly, A., Sen, O., Ganguly, G., Cappai, R., Sahoo, A., & Chakrabarti, S. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-0001-0 · Cited by 26
The dual role of c‐src in cell‐to‐cell transmission of α‐synuclein
Choi, Y. R., Kim, J., Kang, S., Noh, H. R., Jou, I., Joe, E.-H., & Park, S. M. (2020) · EMBO Reports · doi:10.15252/embr.201948950 · Cited by 30
“Given that a -syn is degraded by autophagy [48 – 50], the inhibition of a -syn degradation induces the accumulation of a - syn, further releasing a -syn into the extracellular space via different secretory pathways.”
Cassidy, K. B., & Zhao, H. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00330 · Cited by 29
Parkinson Disease: A Role for Autophagy?
Yang, Q., & Mao, Z. (2010) · The Neuroscientist · doi:10.1177/1073858409357118 · Cited by 29
Zhou, H., Li, S., Li, C., Yang, X., Li, H., Zhong, H., Lu, J., & Lee, S. M. (2020) · Aging and Disease · doi:10.14336/ad.2019.0612 · Cited by 24
Liu, X., & Moussa, C. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.02.004 · Cited by 30
Abe, T., & Kuwahara, T. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.681369 · Cited by 28
“In the following sections, we will discuss the possible roles of these proteins in ALP and α-synuclein metabolism, focusing on the pathological relevance in PD (Figure 1).”
BackgroundInfluentialα-Synuclein Decreases the Abundance of Proteasome Subunits and Alters Ubiquitin Conjugates in Yeast
Popova, B., Gałka, D., Häffner, N., Wang, D., Schmitt, K., Valerius, O., Knop, M., & Braus, G. H. (2021) · Cells · doi:10.3390/cells10092229 · Cited by 25
Zuo, L., Dai, C., Yi, L., & Dong, Z. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00643-5 · Cited by 24
Rahmani, Z., Surabhi, S., Rojo-Cortés, F., Dulac, A., Jenny, A., & Birman, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113078 · Cited by 25
“How then could the higher toxicity of α-synA30P in Lamp1-deficient flies be explained? In mammals, α-synuclein is known to be degraded by various intracellular processes that include the autophagy-lysosomal pathway (macroautophagy [25] and CMA [26]) and the ubiquitin-proteasome system (UPS) [25].”
BackgroundObergasteiger, J., Castonguay, A.-M., Pizzi, S., Magnabosco, S., Frapporti, G., Lobbestael, E., Baekelandt, V., Hicks, A. A., Pramstaller, P. P., Gravel, C., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00484-2 · Cited by 24
Hinault, M., Cuendet, A. F. H., & Goloubinoff, P. (2011) · Neurodegenerative Diseases · doi:10.1159/000324514 · Cited by 26
Lystad, A. H., & Simonsen, A. (2014) · Methods · doi:10.1016/j.ymeth.2014.12.019 · Cited by 27
Role of autophagy in the pathogenesis of Alzheimer disease
Kızılarslanoğlu, M. C., & Ülger, Z. (2015) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1407-75 · Cited by 24
“Macroautophagy and CMA degrade synuclein and this relationship is evidence that autophagy has a critical role in PD progression (24,28).”
BackgroundYamamoto, K., Seki, T., Adachi, N., Takahashi, T., Tanaka, S., Hide, I., Saito, N., & Sakai, N. (2010) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01395.x · Cited by 28
“2006), suggesting that autophagic degradation plays an important role in the prevention of neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, tauopathies and polyglutamine diseases (Webb et al. 2003; Ravikumar et al. 2004; Berger et al. 2006).”
BackgroundThe ER retention protein RER1 promotes alpha-synuclein degradation via the proteasome
Park, H., Ryu, D. H., Parmar, M. S., Giasson, B. I., & McFarland, N. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184262 · Cited by 25
See, S. K., Chen, M., Bax, S., Tian, R., Woerman, A. L., Tse, E., Johnson, I. E., Nowotny, C., Muñoz, E. N., Sengstack, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.21.427704 · Cited by 24
Early Delivery of Misfolded PrP from ER to Lysosomes by Autophagy
Cortes, C. J., Qin, K., Norstrom, E. M., Green, W., Bindokas, V., & Mastrianni, J. A. (2013) · International Journal of Cell Biology · doi:10.1155/2013/560421 · Cited by 23
“Autophagy has been shown to play a role in several longlived proteins associated with neurodegenerative disease, including huntingtin [9], synuclein [10], and beta-amyloid (Aβ) [8].”
BackgroundA Split Transcriptional Repressor That Links Protein Solubility to an Orthogonal Genetic Circuit
Zeng, Y., Jones, A. M., Thomas, E. E., Rausseo, B. N., Silberg, J. J., & Segatori, L. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.8b00129 · Cited by 23
E46K Mutant α-Synuclein Is Degraded by Both Proteasome and Macroautophagy Pathway
Yan, J., Yuan, Y., Chu, S., Li, G., & Chen, N. (2018) · Molecules · doi:10.3390/molecules23112839 · Cited by 24
“This wa similar to the previous report [23].”
BackgroundResultInfluentialLysosomal enzyme activities as possible CSF biomarkers of synucleinopathies
Paciotti, S., Gatticchi, L., Beccari, T., & Parnetti, L. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.03.1627 · Cited by 26
Autophagy at synapses in neurodegenerative diseases
Lee, W., & Kim, S. H. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01148-7 · Cited by 25
Dunlop, R. A., & Carney, J. M. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00168-2 · Cited by 25
Zhang, Z.-N., Hui, Z., Chen, C., Liang, Y., Tang, L., Wang, S., Xu, C., Yang, H., Zhao, Y., & Zhang, J.-S. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s299810 · Cited by 24
RetractedKiely, A. P., Miners, J. S., Courtney, R. J., Strand, C., Love, S., & Holton, J. L. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12512 · Cited by 23
Parkinson’s Disease: To Live or Die by Autophagy
Irrcher, I., & Park, D. S. (2009) · Science Signaling · doi:10.1126/scisignal.265pe21 · Cited by 23
Environmental Toxins and α-Synuclein in Parkinson's Disease
Liu, Y., & Yang, H. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:273 · Cited by 26
“In addition to apoptosis as described earlier, dopaminergic neurons with autophagic vacuoles have been observed in the substantia nigra of PD patients, along with neurons displaying apoptotic features (54,55).”
BackgroundVinexin contributes to autophagic decline in brain ageing across species
Park, S. J., Frake, R. A., Karabiyik, C., Son, S. M., Siddiqi, F. H., Bento, C. F., Sterk, P., Vicinanza, M., Tanasa, M. P., & Rubinsztein, D. C. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00903-y · Cited by 24
“We next expressed A53T mutant alphasynuclein that causes Parkinson’s disease [17] and is also an autophagy substrate [18].”
BackgroundSelf-citationPrecision Medicine in Parkinson’s Disease: From Genetic Risk Signals to Personalized Therapy
Straccia, G., Colucci, F., Eleopra, R., & Cilia, R. (2022) · Brain Sciences · doi:10.3390/brainsci12101308 · Cited by 23
“Apart from autophagy, the UPS system contributes to α-Syn degradation [62].”
BackgroundChwiszczuk, L. J., Breitve, M. H., Kirsebom, B., Selnes, P., Fløvig, J. C., Knapskog, A., Skogseth, R. E., Hubbers, J., Holst‐Larsen, E., & Rongve, A. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1163184 · Cited by 23
“Some of them target the proteasome and autophagy dysfunction and include chaperone-mediated autophagy (CMA) and macroautophagy (Webb et al., 2003; Vogiatzi et al., 2008; Wildburger et al., 2020).”
Quantitative Analysis of α-Synuclein Solubility in Living Cells Using Split GFP Complementation
Kothawala, A., Kilpatrick, K., Novoa, J. A., & Segatori, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043505 · Cited by 25
Verma, D., Ghosh, A., Ruggiero, L., Cartier, E. A., Janezic, E. M., Williams, D., Jung, E., Moore, M., Seo, J. B., & Kim, Y. (2020) · eNeuro · doi:10.1523/eneuro.0134-20.2020 · Cited by 22
“a-Syn is known to be degraded by UPS and the autophagy-lysosome pathway (ALP); however, it is more likely degraded inside lysosomes through chaperonemediated autophagy (CMA) or endocytosis (Webb et al., 2003; Cuervo et al., 2004; Martinez-Vicente and Vila, 2013).”
BackgroundThe role of autophagy in Parkinson's disease.
LeiZhang, Yaru, Dong, & Xiao-heng (2012) · PubMed Central · doi:10.3969/j.issn.1673-5374.2012.02.011 · Cited by 27
“In addition, α-synuclein has been shown to be degraded by autophagy [13-15] .”
BackgroundJellinger, K. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_15 · Cited by 25
The intertwined relationship between circadian dysfunction and Parkinson's disease
Duret, L. C., & Nagoshi, E. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.10.006 · Cited by 22
Siwach, A., Patel, H., Khairnar, A., & Parekh, P. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70192 · Cited by 22
Mu, C., Shao, K., Su, M., Guo, Y., Qiu, Y., Sun, R., Sun, S., Sun, Y., Liu, C., Wang, W., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00902-7 · Cited by 23
Current Understanding of Protein Aggregation in Neurodegenerative Diseases
Hu, C., Lin, M., Wang, C., & Zhang, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110568 · Cited by 26
“When UPS is impaired, autophagy, a lysosome-based degradative process, becomes indispensable for the clearance of these aggregates, thereby preventing cellular toxicity and neurodegeneration [121,122] (Figure 3).”
García‐Juan, M., Ordóñez‐Gutiérrez, L., & Wandosell, F. G. (2023) · Glia · doi:10.1002/glia.24492 · Cited by 22
“The imbalance of autophagy is especially relevant in many neuro-degenerative diseases and has shown an impact in the clearance of protein aggregates in neurons (Frake et al., 2015; Menzies et al., 2017; Qaisiya et al., 2017; Sarkar et al., 2007; Webb et al., 2003; Yamamoto & Simonsen, 2011).”
BackgroundRole of Autophagy in Parkinson’s Disease
Grace, G. Y., Zhang, C., & Lim, K. (2013) · InTech eBooks · doi:10.5772/54927 · Cited by 22
Bae, N.-Y., Chung, S., Kim, H., Cha, J. W., Oh, H., Gu, M., Oh, M. S., & Yang, H. O. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.11.007 · Cited by 22
Proteomics as a new paradigm to tackle Parkinson’s disease research challenges
Licker, V., & Burkhard, P. R. (2014) · Translational Proteomics · doi:10.1016/j.trprot.2014.08.001 · Cited by 22
MSA: From basic mechanisms to experimental therapeutics
Heras‐Garvin, A., & Stefanova, N. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.01.010 · Cited by 21
Remodeling microglia to a protective phenotype in Parkinson’s disease?
Awogbindin, I. O., Ishola, I. O., St‐Pierre, M., Carrier, M., Savage, J. C., Paolo, T. D., & Tremblay, M. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135164 · Cited by 23
Dansithong, W., Paul, S., Scoles, D. R., Pulst, S. M., & Huynh, D. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136930 · Cited by 21
“The ubiquitin-proteasomal pathway [64] mostly mediates wild type α-synuclein clearance, while clearance of aggregated, misfolded, or accumulated α-synuclein occurs through the autophagy dependent lysosomal pathway [65,66].”
BackgroundBeclin1/PI3K-Mediated Autophagy Prevents Hypoxia-Induced Apoptosis in EAhy926 Cell Line
Zhang, R., Zhu, F., Ren, J., Huang, L., Liu, P., & Wu, G. (2011) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2010.0814 · Cited by 21
“22 MAPK p38 has a dual role in autophagy, both as a positive and negative regulator.”
Proteasome regulates turnover of toxic human amylin in pancreatic cells
Singh, S., Trikha, S., Sarkar, A. A., & Jeremic, A. M. (2016) · Biochemical Journal · doi:10.1042/bcj20160026 · Cited by 21
Epothilone D inhibits microglia-mediated spread of alpha-synuclein aggregates
Valdinocci, D., Grant, G. D., Dickson, T. C., & Pountney, D. L. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.04.006 · Cited by 20
“Other works have shown that microglia actively degrade monomeric α-syn whilst the current results indicate that both THP-1 and differentiated THP-1 cells can degrade α-syn monomer (Webb et al., 2003).”
ResultAutophagy and UPS pathway contribute to nicotine-induced protection effect in Parkinson’s disease
Ullah, I., Shahab Uddin, M. S., Zhao, L., Wang, X., & Li, H. (2024) · Experimental Brain Research · doi:10.1007/s00221-023-06765-9 · Cited by 20
Nuclear proteasomes buffer cytoplasmic proteins during autophagy compromise
Park, S. J., Son, S. M., Barbosa, A. D., Wróbel, L., Stamatakou, E., Squitieri, F., Balmus, G., & Rubinsztein, D. C. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01488-7 · Cited by 22
“The A53T α-synuclein (A53T α-Syn) mutant, which causes autosomal dominant PD, is cleared by both autophagy and the proteasome 17 , the two major intracellular clearance pathways.”
Self-citationPhosphorylatedα-Synuclein-Copper Complex Formation in the Pathogenesis of Parkinson’s Disease
Castillo-González, J. A., Loera‐Arias, M. D. J., Cárdenas, O. S., Montes‐de‐Oca‐Luna, R., García‐García, A., & Rodríguez‐Rocha, H. (2017) · Parkinson s Disease · doi:10.1155/2017/9164754 · Cited by 25
“Importantly, both degradation pathways are dysregulated or inhibited in PD [52].”
Puska, G., Lutz, M. I., Molnár, K., Regelsberger, G., Ricken, G., Pirker, W., László, L., & Kovács, G. G. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.02.019 · Cited by 20
Seranova, E., Palhegyi, A. M., Verma, S., Dimova, S., Lasry, R., Naama, M., Sun, C., Barrett, T. G., Rosenstock, T. R., Kumar, D., et al. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.024 · Cited by 23
A Glimmer of Hope: Maintain Mitochondrial Homeostasis to Mitigate Alzheimer’s Disease
Li, W., Kui, L., Tsirukis, D. I., Gong, X., & Tang, M. (2020) · Aging and Disease · doi:10.14336/ad.2020.0105 · Cited by 22
“The in vitro work examining the effect of autophagy upregulation on the clearance of aggregation-prone proteins caused by polyQ and polyA expansions, mutant tau, and ataxin-3 [131, 132] and mutant α-synuclein [133, 134] has suggested reductions in both of associated cell death and intracytoplasmic aggregates.”
BackgroundHepcidin Decreases Rotenone-Induced α-Synuclein Accumulation via Autophagy in SH-SY5Y Cells
Li, M., Hu, J., Yuan, X., Shen, L., Zhu, L., & Luo, Q. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.560891 · Cited by 21
“Some studies showed that both the proteasome system and the autophagy pathway eliminated α-syn (Webb et al., 2003).”
BackgroundPalomino, O. M., García-Aguilar, A., González, A., Guillén, C., Benito, M., & Goya, L. (2021) · Molecules · doi:10.3390/molecules26164829 · Cited by 20
“For instance, autophagy-inducing agents such rapamycin, a relatively selective inhibitor of mTORC1, reduce intracellular aggregates of toxic proteins in neurodegenerative diseases, such as β-amyloid levels in Alzheimer’s disease [14], α-synuclein in Parkinson’s disease [15], or huntingtin species in Huntington’s disea…”
BackgroundOe, Y., Kakuda, K., Yoshimura, S., Hara, N., Hasegawa, J., Terawaki, S., Kimura, Y., Ikenaka, K., Suetsugu, S., Mochizuki, H., et al. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010264 · Cited by 20
Rhythms in barriers and fluids: Circadian clock regulation in the aging neurovascular unit
Skapetze, L., Owino, S., Lo, E. H., Arai, K., Merrow, M. W., & Harrington, M. E. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106120 · Cited by 20
“Autophagy has also been specifically linked to α-synuclein accumulation in Parkinson’s disease (Webb et al., 2003), mutant TDP-43 accumulation in amyotrophic lateral sclerosis (Barmada et al., 2014), and mutant tau accumulation in various forms of dementia (Berger et al., 2006).”
Selective Autophagy inDrosophila
Nezis, I. P. (2012) · International Journal of Cell Biology · doi:10.1155/2012/146767 · Cited by 21
“Autophagy has been shown to be responsible for the selective degradation of proteins in mammals and yeast like betasynuclein [55], catalase [56], and acetaldehyde dehydrogenase [57].”
BackgroundRobinson, P. A. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.40 · Cited by 22
Oláh, J., Bertrand, P., & Ovádi, J. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1304216 · Cited by 20
The role of autophagy in neurodegenerative diseases
Kochergin, I. A., & Zakharova, M. N. (2016) · Neurochemical Journal · doi:10.1134/s1819712416010098 · Cited by 23
The Role of Chaperones in Parkinson’s Disease and Prion Diseases
Winklhofer, K. F., & Tatzelt, J. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-29717-0_10 · Cited by 22
“In other studies, the lysosomal degradation pathway was shown to be involved in the clearance of α-synuclein (Lee et al. 2004; Webb et al. 2003).”
BackgroundLin, T.-K., Lin, K.-J., Lin, K.-L., Liou, C.-W., Chen, S.-D., Chuang, Y.-C., Wang, P.-W., Chuang, J.-H., & Wang, T.-J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.607392 · Cited by 19
“The clearance of α-syn is primarily mediated through autophagic-lysosomal systems, in which aggregated forms are degraded through (macro)autophagy and soluble forms through chaperone-mediated autophagy (Webb et al., 2003; Martinez-Vicente and Vila, 2013).”
BackgroundM'angale, P. G., & Staveley, B. E. (2016) · Genetics and Molecular Research · doi:10.4238/gmr15048953 · Cited by 21
Shaikh, S., Ahmad, K., Ahmad, S. S., Lee, E. J., Lim, J. H., Beg, M. M. A., Verma, A. K., & Choi, I. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6347792 · Cited by 19
“Various studies have reported that autophagy can degrade all forms of αsynuclein [77, 78] and that proteasomes also degrades monomeric α-synuclein [79].”
BackgroundBeyond Strains: Molecular Diversity in Alpha-Synuclein at the Center of Disease Heterogeneity
Wojewska, M. J., Otero‐Jimenez, M., Guijarro-Nuez, J., & Alegre‐Abarrategui, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713199 · Cited by 19
“Enzymes are known to exhibit protein–substrate stereoselectivity; thus, demonstrating an alternate chirality may inhibit the enzymatic degradation of α-syn via the autophagy or ubiquitinproteasome pathway [65].”
BackgroundSechi, G., & Sechi, M. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011198 · Cited by 20
“(3) The increased intracellular clearance of α -syn via activation of either the ubiquitin-proteasome system (for normal monomeric α -syn) [74,75], or of the authophagy/ lysosomal pathway (for aggregated α -syn) [76,77].”
BackgroundTherapeutic advances in multiple system atrophy and progressive supranuclear palsy
Poewe, W. H., Mahlknecht, P., & Krismer, F. (2015) · Movement Disorders · doi:10.1002/mds.26334 · Cited by 19
“Lithium was selected as a potential diseasemodifying agent in MSA based on preclinical findings of lithium-induced autophagy via inhibition of inositol monophosphatase,(12) which might enhance autophagosomal clearance of a-synuclein.(13) Based on these findings, Sacca and colleagues(14) initiated a placebocontrolled p…”
BackgroundImpairment of autophagy by TTR V30M aggregates: in vivo reversal by TUDCA and curcumin
Teixeira, C. A., Almeida, M. R., & Saraiva, M. J. (2016) · Clinical Science · doi:10.1042/cs20160075 · Cited by 19
Villar‐Piqué, A., & Ventura, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.023 · Cited by 19
The role of α-synuclein in neurodegeneration — An update
Jellinger, K. A. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0013-1 · Cited by 23
Sass, M. B., Lorenz, A. N., Green, R. L., & Coleman, R. A. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.12.014 · Cited by 21
Lipid vesicles affect the aggregation of 4-hydroxy-2-nonenal-modified α-synuclein oligomers
Sinha, M. S., Giraldo, A. M. V., Öllinger, K. M., Hallbeck, M., & Civitelli, L. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.06.020 · Cited by 20
Höllerhage, M., Fussi, N., Rösler, T. W., Wurst, W., Behrends, C., & Höglinger, G. U. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.01.023 · Cited by 21
“Mechanisms for intracellular degradation of α-Syn comprise the ubiquitin-proteasome system (UPS) (Webb et al., 2003) and the autophagy-lysosomal system including chaperone-mediated autophagy (CMA) (Cuervo et al., 2004), and macroautophagy (Webb et al., 2003).”
BackgroundPech, U., Janssens, J., Schoovaerts, N., Kuenen, S., Calatayud, C., Gallego, S. F., Makhzami, S., Hulselmans, G. J., Poovathingal, S. K., Davie, K., et al. (2025) · eLife · doi:10.1101/2023.03.11.532176 · Cited by 18
“The presence of protein aggregates in these areas is consistent with protein homeostasis and synaptic defects that ultimately contribute to the aggregation of alpha-Synuclein (Chu et al., 2009; Friedman et al., 2012; Sarkar et al., 2007; Webb et al., 2003).”
BackgroundChandran, A., Oliver, H., & Rochet, J. (2023) · Biology · doi:10.3390/biology12091169 · Cited by 19
Cóppola-Segovia, V., & Reggiori, F. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168493 · Cited by 18
Xue, D., Wang, Q., Chen, Z., Cai, L., Li, B., Qi, Q., Liu, L., Wang, X., Jin, H., Wang, J., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.02.030 · Cited by 19
Protection against neurotoxicity by an autophagic mechanism
Liu, K., Huang, J., Chen, R., Zhang, T., Shen, L., Yang, J., & Sun, X. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500039 · Cited by 20
“Stimulation of autophagic activity by rapamycin enhanced the clearance of α-synuclein (10).”
BackgroundInfluentialIn Vitro Screening Platforms for Identifying Autophagy Modulators in Mammalian Cells
Seranova, E., Ward, C., Chipara, M., Rosenstock, T. R., & Sarkar, S. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-8873-0_26 · Cited by 18
mTOR Mysteries: Nuances and Questions About the Mechanistic Target of Rapamycin in Neurodegeneration
Norwitz, N. G., & Querfurth, H. W. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00775 · Cited by 18
“…diseases, such as amyloid-β (Aβ) (Nixon, 2007; Nilsson et al., 2013; Yang et al., 2014), phospho-tau (Hamano et al., 2008; Kruger et al., 2012; Wang and Mandelkow, 2012), α-synuclein (Webb et al., 2003; Lee et al., 2004; Xilouri et al., 2016), and mutant huntingtin (Martin et al., 2015).”
Won, S.-Y., Park, J., You, S.-T., Hyeun, J.-A., Kim, H. K., Jin, B. K., McLean, C., Shin, E., & Kim, E. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05030-1 · Cited by 18
“Autophagy/ubiquitin-dependent proteolytic systems are involved in the clearance of α-synuclein aggregates [23, 47].”
BackgroundWang, R., Zhao, J., Zhang, J., Liu, W., Zhao, M.-Y., LI, J., Lv, J., & LI, Y. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2432 · Cited by 18
A New Autophagy-related Checkpoint in the Degradation of an ERAD-M Target
Kario, E., Amar, N., Elazar, Z., & Navon, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.177618 · Cited by 19
Autophagy as an antimicrobial strategy
Subauste, C. S. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.41 · Cited by 21
Does autophagy worsen or improve the survival of dopaminergic neurons?
Pasquali, L., Ruggieri, S. A., Murri, L., Paparelli, A., & Fornai, F. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70830-2 · Cited by 19
“ATG and CMA degrade a variety of misfolded proteins, including alpha-synuclein [3] and altered mitochondria [4].”
BackgroundVats, K., Gourie‐Devi, M., Ahuja, K., Sharma, A., Wajid, S., Ganguly, N. K., & Taneja, V. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.01.035 · Cited by 18
A Brain Aggregate Model Gives New Insights Into the Pathobiology and Treatment of Prion Diseases
Bajsarowicz, K., Ahn, M., Ackerman, L. D., DeArmond, B., Carlson, G. A., & DeArmond, S. J. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182544680 · Cited by 18
“Beneficial effects of Rap have been reported for spinocerebellar ataxia (32), Parkinson disease (33), frontotemporal lobar degeneration (34), Huntington disease (35), and amyotrophic lateral sclerosis (36).”
Backgroundp37 regulates VCP/p97 shuttling and functions in the nucleus and cytosol
Wróbel, L., Hoffmann, J. L., Li, X., & Rubinsztein, D. C. (2024) · Science Advances · doi:10.1126/sciadv.adl6082 · Cited by 21
“…mutant protein and puromycin-induced misfolded proteins are substrates of both the ubiquitin-proteasome system and autophagy ( 11 , 31 , 32 ). siRNA-mediated depletion of p37 caused an accumulation of α - synuclein–A53T mutant protein in both WT and autophagy-deficient ATG7 KO cells…”
BackgroundSelf-citationLandrock, K. K., Sullivan, P., Martini‐Stoica, H., Goldstein, D. S., Graham, B. H., Yamamoto, S., Bellen, H. J., Gibbs, R. A., Chen, R., D’Amelio, M., et al. (2017) · Brain Research · doi:10.1016/j.brainres.2017.11.029 · Cited by 19
A comprehensive phenotypic characterization of a whole-body Wdr45 knock-out mouse
Biagosch, C., Vidali, S., Faerberboeck, M., Hensler, S.-V., Becker, L., Amarie, O. V., Aguilar‐Pimentel, J. A., Garrett, L., Klein‐Rodewald, T., Rathkolb, B., et al. (2021) · Mammalian Genome · doi:10.1007/s00335-021-09875-3 · Cited by 19
“While dividing cells can dilute dysfunctional mitochondria, neuronal cells accumulate them, leading to neurodegeneration (Ravikumar et al. 2002; Webb et al. 2003; Berger et al. 2006).”
Shadfar, S., Khanal, S., Bohara, G., Kim, G., Sadigh‐Eteghad, S., Ghavami, S., Choi, H., & Choi, D. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02943-y · Cited by 21
“Indeed, autophagy inducers such as rapamycin and lithium reduced α‐synuclein accumulation and prevented neurodegeneration in vitro [48] and in vivo [49, 50].”
BackgroundPathological Pathways and Alpha-Synuclein in Parkinson's Disease: A View from the Periphery
Basellini, M. J., Kothuis, J. M., Comincini, A., Pezzoli, G., Cappelletti, G., & Mazzetti, S. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2802033 · Cited by 21
“…in PC12 cells demonstrated an expected increase in wild-type alpha-synuclein after inhibiting macroautophagy with 3-Methyladenine, whereas others reported that 3-Methyladenine macroautophagy inhibition results in a sig-8 nificant increase of mutant A53T but not wild-type alpha-synuclein [127].”
BackgroundThreonine 53 in α-synuclein is conserved in long-living non-primate animals
Larsen, K., Hedegaard, C., Bertelsen, M. F., & Bendixen, C. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.070 · Cited by 17
Miners, J. S., Renfrew, R., Swirski, M., & Love, S. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0164-0 · Cited by 19
Snapin deficiency is associated with developmental defects of the central nervous system
Zhou, B., Zhu, Y.-B., Lin, L., Cai, Q., & Sheng, Z. (2010) · Bioscience Reports · doi:10.1042/bsr20100110 · Cited by 18
Metadata
- Authors
- Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C.
- Affiliations
- Addenbrooke's Hospital (GB)
- University of Cambridge (GB)
- Corresponding author
- Rubinsztein, David C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-07
- Volume
- 278
- Issue
- 27
- Pages
- 25009-25013
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2157535220
- Cited by
- 1,429
- References
- 37
- Citations by year
- 2026: 36 · 2025: 41 · 2024: 76 · 2023: 50 · 2022: 68 · 2021: 71 · 2020: 83 · 2019: 85 · 2018: 77 · 2017: 62 · 2016: 65 · 2015: 65 · 2014: 75 · 2013: 79 · 2012: 95
- FWCI
- 18.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6305 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Parkinson's UK
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- alpha-synuclein, Parkinson's disease, autophagy, proteasome, protein degradation, Lewy bodies, A30P mutation, A53T mutation, PC12 cells, rapamycin, autophagic vesicles, dopaminergic neurons
- MeSH terms
- Animals, Antibiotics, Antineoplastic, Autophagy, Cysteine Endopeptidases, Humans, Multienzyme Complexes, Nerve Tissue Proteins, PC12 Cells, Sirolimus, Proteasome Endopeptidase Complex, Rats, Synucleins, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.